Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload
When its missing, everything starts to slow down metabolism, focus, mood, even sleep
Overdosing can lead to elevated B12 levels and potential side effects, while underdosing may not adequately address symptoms
Usage Guidelines : If considering BPC-157, it's advised to use minimal effective doses (300-500 micrograms 2-3 times a week) and monitor for any adverse effects, particularly signs related to cancer or tumor development 2
Then, turn the vial upside down and carefully draw your desired amount of water (1mL or 2mL)